Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes (Q74455329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Maria Leite-De-Moraes

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Toshinori Nakayama

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Agnes Lehuen

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Sharif S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Arreaza GA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Zucker P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Mi QS

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sondhi J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Naidenko OV

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kronenberg M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Koezuka Y

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Delovitch TL

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Gombert JM

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Gouarin C

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Zhu R

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hameg A

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Taniguchi M

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lepault F

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Bach JF

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Herbelin A

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1057-1062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm0901-1057

10 November 2019

exact match

0 references

cites work

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Proliferation of donor-derived NKR-P1+TCR alpha beta + (NKT) cells in the nonrecurrent spontaneous diabetic BB rats transplanted with pancreaticoduodenal grafts of Wistar-Furth donors

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1057

7 January 2021

Identifiers

DOI

10.1038/NM0901-1057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533711%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference